CLINICAL_TRIALS
withdrawal
· 2025-03-07
Clinical Trial Update: The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures [Phase 1, Phase 2]
Summary
A phase 1/2 clinical trial evaluating sugammadex for postoperative urinary retention in patients undergoing pelvic floor reconstructive procedures has been with…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: West Virginia University | Conditions: Postoperative Urinary Retention | Phase 1, Phase 2 | Status: WITHDRAWN